ghost dyetmuv450viability dye (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
93
Structured Review
Cell Signaling Technology Inc
ghost dyetmuv450viability dye
Ghost Dyetmuv450viability Dye, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ghost+dyetmuv450viability+dye/Ghost+Dye+UV+450+Fixable+Viability+Dye/10__1002_slash_jlb__1ma0422___518rr-189-50-53
Average 93 stars, based on 4 article reviews
Ghost Dyetmuv450viability Dye, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ghost+dyetmuv450viability+dye/Ghost+Dye+UV+450+Fixable+Viability+Dye/10__1002_slash_jlb__1ma0422___518rr-189-50-53
Average 93 stars, based on 4 article reviews
ghost dyetmuv450viability dye - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Single Cell:Article Title: c-Rel-dependent monocytes are potent immune suppressor cells in cancer Article Snippet: .. Single-cell suspensions from isolated tissues and cultured BM-MDSC cells were suspended in FACS buffer and incubated for 20 min with fluorescence-labeled antibodies with the different combinations of the following antibodies: CD45.1 (BioLegend; 110743), CD45.2 (BioLegend; 109828), CD11b (BioLegend; 101208), F4/80 (BioLegend; 123115), CCR2 (BioLegend; 150611), CD8 (BioLegend; 100714), CD4 (Invitrogen;MCD0404-3), Isolation:Article Title: c-Rel-dependent monocytes are potent immune suppressor cells in cancer Article Snippet: .. Single-cell suspensions from isolated tissues and cultured BM-MDSC cells were suspended in FACS buffer and incubated for 20 min with fluorescence-labeled antibodies with the different combinations of the following antibodies: CD45.1 (BioLegend; 110743), CD45.2 (BioLegend; 109828), CD11b (BioLegend; 101208), F4/80 (BioLegend; 123115), CCR2 (BioLegend; 150611), CD8 (BioLegend; 100714), CD4 (Invitrogen;MCD0404-3), Cell Culture:Article Title: c-Rel-dependent monocytes are potent immune suppressor cells in cancer Article Snippet: .. Single-cell suspensions from isolated tissues and cultured BM-MDSC cells were suspended in FACS buffer and incubated for 20 min with fluorescence-labeled antibodies with the different combinations of the following antibodies: CD45.1 (BioLegend; 110743), CD45.2 (BioLegend; 109828), CD11b (BioLegend; 101208), F4/80 (BioLegend; 123115), CCR2 (BioLegend; 150611), CD8 (BioLegend; 100714), CD4 (Invitrogen;MCD0404-3), FACS:Article Title: c-Rel-dependent monocytes are potent immune suppressor cells in cancer Article Snippet: .. Single-cell suspensions from isolated tissues and cultured BM-MDSC cells were suspended in FACS buffer and incubated for 20 min with fluorescence-labeled antibodies with the different combinations of the following antibodies: CD45.1 (BioLegend; 110743), CD45.2 (BioLegend; 109828), CD11b (BioLegend; 101208), F4/80 (BioLegend; 123115), CCR2 (BioLegend; 150611), CD8 (BioLegend; 100714), CD4 (Invitrogen;MCD0404-3), Incubation:Article Title: c-Rel-dependent monocytes are potent immune suppressor cells in cancer Article Snippet: .. Single-cell suspensions from isolated tissues and cultured BM-MDSC cells were suspended in FACS buffer and incubated for 20 min with fluorescence-labeled antibodies with the different combinations of the following antibodies: CD45.1 (BioLegend; 110743), CD45.2 (BioLegend; 109828), CD11b (BioLegend; 101208), F4/80 (BioLegend; 123115), CCR2 (BioLegend; 150611), CD8 (BioLegend; 100714), CD4 (Invitrogen;MCD0404-3), Fluorescence:Article Title: c-Rel-dependent monocytes are potent immune suppressor cells in cancer Article Snippet: .. Single-cell suspensions from isolated tissues and cultured BM-MDSC cells were suspended in FACS buffer and incubated for 20 min with fluorescence-labeled antibodies with the different combinations of the following antibodies: CD45.1 (BioLegend; 110743), CD45.2 (BioLegend; 109828), CD11b (BioLegend; 101208), F4/80 (BioLegend; 123115), CCR2 (BioLegend; 150611), CD8 (BioLegend; 100714), CD4 (Invitrogen;MCD0404-3), |